Boule Diagnostics AB (publ) (STO:BOUL)
Sweden
· Delayed Price · Currency is SEK 8.02
0.00 (0.00%)
Jun 19, 2025, 5:29 PM CET
Boule Diagnostics AB Revenue
Boule Diagnostics AB had revenue of 112.90M SEK in the quarter ending March 31, 2025, a decrease of -23.61%. This brings the company's revenue in the last twelve months to 523.56M, down -9.11% year-over-year. In the year 2024, Boule Diagnostics AB had annual revenue of 558.46M, down -2.25%.
Revenue (ttm)
523.56M
Revenue Growth
-9.11%
P/S Ratio
0.59
Revenue / Employee
2.62M
Employees
200
Market Cap
311.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 558.46M | -12.87M | -2.25% |
| Dec 31, 2023 | 571.33M | 23.24M | 4.24% |
| Dec 31, 2022 | 548.09M | 84.74M | 18.29% |
| Dec 31, 2021 | 463.34M | 62.89M | 15.70% |
| Dec 31, 2020 | 400.46M | -98.46M | -19.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |
Boule Diagnostics AB News
- 4 months ago - Q4 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus
- 8 months ago - Q3 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus